Journal
INTERNATIONAL JOURNAL OF OBESITY
Volume 29, Issue 9, Pages 1130-1136Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.ijo.0803001
Keywords
appetite; ghrelin; food intake; growth hormone secretagogues
Categories
Funding
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
OBJECTIVE: To investigate whether effects on food intake are seen in obese subjects receiving exogenous administration of ghrelin. DESIGN: Randomised, double-blind, placebo-controlled study of intravenous ghrelin at doses 1 pmol/kg/min and 5 pmol/kg/min. SUBJECTS: In all, 12 healthy lean subjects (mean body mass index (BMI) 20.5 +/- 0.17 kg/m(2)) and 12 healthy overweight and obese subjects (mean BMI 31.9 +/- 1.02 kg/m(2)). MEASUREMENTS: Food intake, appetite and palatability of food, ghrelin and other obesity-related hormones, growth hormone. RESULTS: Low-dose infusion of ghrelin increased ad libitum energy intake at a buffet meal in the obese group only (mean increase 36.6 +/- 9.4%, P < 0.01.) High-dose ghrelin infusion increased energy intake in both groups ( mean increase 20.1 +/- 10.6% in the lean and 70.1 +/- 15.5% in the obese, P < 0.01 in both cases.) Ghrelin infusion increased palatability of food in the obese group. CONCLUSION: Ghrelin increases food intake in obese as well as lean subjects. Obese people are sensitive to the appetite-stimulating effects of ghrelin and inhibition of circulating ghrelin may be a useful therapeutic target in the treatment of obesity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available